|
시장보고서
상품코드
2055349
세포 및 유전자 치료 시장 : 치료법별, 용도별, 최종사용자별, 지역별Cell and Gene Therapy Market, By Therapy Type, By Application, By End User, By Geography |
||||||
세포 및 유전자 치료 시장은 2026년 447억 5,000만 달러로 추정되며, 2033년까지 1,485억 8,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 18.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 447억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 18.70% | 2033년 시장 규모 예측 : | 1,485억 8,000만 달러 |
세포 치료란, 질환을 치료하기 위해 환자의 체내에 새로운 세포를 주입하여 손상된 조직을 성장시키거나, 대체하거나, 복원하는 치료법입니다. 세포 치료에는 줄기세포, 림프구, 수지상세포 등 다양한 유형의 세포가 사용됩니다. 세포 치료에서는 환자 자신의 몸에서 채취한 세포(자가 세포) 또는 기증자로부터 얻은 세포(동종 세포)를 사용할 수 있습니다. 많은 세포 치료법에서는 유전자 조작을 통해 재프로그래밍되어 환자의 체내에서 다양한 세포 유형으로 분화할 수 있는 성체 세포가 사용되고 있습니다. 이 기술을 통해 치료 목적으로 필요한 모든 유형의 인간 세포를 무제한으로 생성할 수 있게 될지도 모릅니다.
유전자 치료는 질환의 치료, 예방 또는 잠재적인 완치를 목적으로 환자의 체내 유전자를 변형하거나 유전자를 도입하는 것을 목표로 합니다. 유전자 치료의 접근 방식으로는 질환의 원인이 되는 변이 유전자를 정상적인 유전자로 교체하거나, 새로운 정상 유전자의 사본을 체내에 도입하는 것 등이 있습니다.
시장 역학
세포 및 유전자 치료는 유전자 조절, 세포 간 상호작용, 재생 능력 및 리모델링에 활용할 수 있는 개념과 기술을 제공함으로써 현대 의료 분야에서 중요한 역할을 수행하고 있습니다. 따라서 주요 시장 참여자들은 제품 및 플랫폼 출시 등 다양한 성장 전략을 도입하는 데 주력하고 있으며, 이는 예측 기간 동안 시장 성장을 견인할 것으로 기대됩니다. 예를 들어, 2023년 4월 4일, 세계 헬스케어 기업인 아메리스소스버겐(AmerisourceBergen)은 바이오의약품 기업 및 의료 제공업체용 플랫폼과 통합 가능한 시스템인 ‘Cell and Gene Therapy(CGT) Integration Hub’의 출시를 발표했습니다. 이 시스템은 실시간 데이터 교환을 촉진하고, 치료 개발부터 환자의 치료 경과에 이르기까지 서비스 조정을 지원하는 것입니다.
또한, 플랫폼에 구애받지 않고 아메리스소스버겐의 혁신적인 고객 관계 관리(CRM) 시스템을 기반으로 하는 ‘CGT 통합 허브’는 치료법 개발 및 제공 전 과정에 걸친 가시성을 의료진과 환자 서비스 팀에 제공함으로써, 치료 과정을 효율화하는 것을 목표로 하고 있습니다. 플랫폼과의 통합을 통해, CGT 통합 허브는 다음과 같은 기능을 제공합니다.
- 급여 심사 절차를 신속하게 진행하여, 의사가 환자의 등록 데이터를 입력한 후 거의 즉시 환자의 보험 적용 여부에 대한 결정을 받을 수 있도록 합니다.
- 환자의 일정 조정을 원활하게 하기 위해, 의사와 케어 매니저가 치료법 개발 현황 및 이송 관련 정보에 실시간으로 접근할 수 있도록 합니다.
- 도착일 연기 등 상황의 변화가 있을 경우 케이스 매니저에게 알리고, 필요에 따라 예정된 치료 관련 활동이나 입원 일정을 변경할 수 있도록 환자나 보호자에게 사전에 연락할 수 있도록 합니다.
본 조사의 주요 특징
- 본 조사는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 세포 및 유전자 치료 시장의 주요 기업들을 분석했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 세포 및 유전자 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 세포 및 유전자 치료 시장 : 요법 유형별, 2021년-2033년
제5장 세계의 세포 및 유전자 치료 시장 : 용도별, 2021년-2033년
제6장 세계의 세포 및 유전자 치료 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 세포 및 유전자 치료 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSHCell And Gene Therapy Market is estimated to be valued at USD 44.75 Bn in 2026 and is expected to reach USD 148.58 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 44.75 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 18.70% | 2033 Value Projection: | USD 148.58 Bn |
Cell therapy is the introduction of new cells into a patient's body to grow, replace, or repair damaged tissue in order to treat a disease. A variety of different types of cells can be used in cell therapy, including stem cells, lymphocytes, and dendritic cells. Cell therapies can use cells from the patient's own body (autologous) or from a donor (allogenic). Many cell therapies use adult cells that have been genetically reprogrammed and capable of becoming one of many types of cells inside a patient's body. This technology may enable the development of unlimited types of specific human cells needed for therapeutic purposes.
Gene therapy seeks to modify or introduce genes into a patient's body with the goal of treating, preventing, or potentially curing a disease. Examples of gene therapy approaches include replacing a mutated gene that causes disease with a functional copy or introducing a new, correct copy of a gene into the body.
Market Dynamics
Cell and gene therapy plays a major role in modern healthcare, as it provides concepts and techniques that can be used in gene regulation, cell-cell interactions, regenerative capacity, and remodeling. Thus, key market players are focused on adopting various growth strategies such as product/platform launches and others, which in turn is expected to fuel the market growth over the forecast period. For instance, on April 4, 2023, AmerisourceBergen, a global healthcare company, announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey.
Furthermore, The CGT Integration Hub, which is platform-agnostic and powered by AmerisourceBergen's innovative customer relationship management (CRM) system, aims to streamline the path-to-care process, in part, by providing physicians and patient services teams with enhanced visibility across the therapy development and delivery process. Through platform integrations, the CGT Integration Hub can
- Speed up the benefits investigation process so that after physicians enter patient enrollment data, they can get a decision on the patient's coverage almost immediately.
- To facilitate patient scheduling, give doctors and care managers real-time access to information on the status of the development of the therapy and transportation.
- Inform case managers of any status changes, such as postponed arrival dates, so they can contact patients and caregivers in advance to amend any scheduled treatment-related activities or stays, as necessary.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cell and gene therapy market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., Bluebird Bio, Inc. (Celgene Corporation) , Biogen Inc., uniQure N.V., JCR Pharmaceuticals Co. Ltd., Gene Biotherapeutics, Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Organogenesis, Inc., Orchard Therapeutics Plc., Freeline Therapeutics Ltd. , Bristol-Myers Squibb Company, PTC Therapeutics, Inc., Spark Therapeutics, Inc. and Biomarin Pharmaceutical Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell and gene therapy market.
Market Segmentation
- Global Cell and Gene Therapy Market, By Therapy Type (Revenue, USD Bn, 2021 - 2033)
- Cell Therapy
- Stem Cells
- T Cells
- Dendritic Cells
- NK Cells
- Gene Therapy
- Germline Gene Therapy
- Somatic Gene Therapy
- Global Cell and Gene Therapy Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Dermatology
- Musculoskeletal
- Oncology
- Immunology
- Cardiology & Neurology
- Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
- Global Cell and Gene Therapy Market, By End user (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics
- Others (Research Institutes, Academic Institutes, etc.)
- Global Cell and Gene Therapy Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Novartis International AG
- Pfizer, Inc.
- Sanofi S.A.
- Amgen, Inc.
- Regeneron Pharmaceuticals, Inc.
- Bluebird Bio, Inc. (Celgene Corporation)
- Biogen Inc.
- uniQure N.V.
- JCR Pharmaceuticals Co. Ltd.
- Gene Biotherapeutics
- Kolon TissueGene, Inc.
- Horama S.A.
- MeiraGTx Limited
- Gilead Sciences, Inc.
- Organogenesis, Inc.
- Orchard Therapeutics Plc.
- Freeline Therapeutics Ltd.
- Bristol-Myers Squibb Company
- PTC Therapeutics, Inc.
- Spark Therapeutics, Inc.
- Biomarin Pharmaceutical Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Application
- Market Snapshot, By End user
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Technological Advancements
- Manufacturer Revenue
- Pipeline Analysis
4. Global Cell and Gene Therapy Market, By Therapy Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Stem Cells
- T Cells
- Dendritic Cells
- NK Cells
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Germline Gene Therapy
- Somatic Gene Therapy
5. Global Cell and Gene Therapy Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Cardiology & Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
- Others (Urinary Problems, Infectious Disease, Ophthalmic, Diseases, Retinal Diseases, And Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
6. Global Cell and Gene Therapy Market, By End user, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Research Institutes, Academic Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cell and Gene Therapy Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bluebird Bio, Inc. (Celgene Corporation)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- uniQure N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JCR Pharmaceuticals Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gene Biotherapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kolon TissueGene, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Horama S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MeiraGTx Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Organogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Orchard Therapeutics Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Freeline Therapeutics Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PTC Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Spark Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomarin Pharmaceutical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
